Literature DB >> 203177

Plasma norepinephrine in congestive heart failure.

J A Thomas, B H Marks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203177     DOI: 10.1016/0002-9149(78)90162-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  134 in total

1.  Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.

Authors:  K Leineweber; T Seyfarth; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Forearm vasoconstriction during dynamic leg exercise in patients with chronic heart failure.

Authors:  J J Atherton; L G Dryburgh; H L Thomson; T D Moore; K N Wright; G W Muehle; L E Fitzpatrick; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

3.  Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status.

Authors:  J J Atherton; D J Blackman; T D Moore; A W Bachmann; T J Tunny; H L Thomson; R D Gordon; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

4.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

Review 5.  Centrally acting sympatholytic agents in the treatment of congestive heart failure. A review of the literature.

Authors:  A Manmontri; S M MacLeod
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 6.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

7.  Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

Authors:  C S Liang; T H Fan; J T Sullebarger; S Sakamoto
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 8.  Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure.

Authors:  A J Coats; S Adamopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

9.  The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.

Authors:  Michael D Kritzer; Jinliang Li; Catherine L Passariello; Marjorie Gayanilo; Hrishikesh Thakur; Joseph Dayan; Kimberly Dodge-Kafka; Michael S Kapiloff
Journal:  Circ Heart Fail       Date:  2014-05-08       Impact factor: 8.790

10.  Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.

Authors:  Dan Li; Chieh-Ju Lu; Guoliang Hao; Hannah Wright; Lavinia Woodward; Kun Liu; Elisa Vergari; Nicoletta C Surdo; Neil Herring; Manuela Zaccolo; David J Paterson
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.